Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques

Neuropsychopharmacology

Volumn 29, Issue 11, 2004, Pages 2035-2045

  Smith, Lisa J ^a   Henderson, Jessica A ^a   Abell, Creed W ^c   Bethea, Cynthia L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Estrogen; Macaques; Monoamine oxidases; Phosphorylation; Progesterone; Raloxifene; Reuptake transporter; Selective estrogen receptor modulator; SERM; Serotonin; Tryptophan hydroxylase; Western blots

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CITALOPRAM; ESTRADIOL; MESSENGER RNA; PHOSPHOSERINE; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN; SEROTONIN TRANSPORTER; STEROID; TRITIUM; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ARTICLE; DORSAL RAPHE NUCLEUS; ESTROGEN BLOOD LEVEL; FEMALE; HORMONE ACTION; HYSTERECTOMY; MACACA; MESENCEPHALON; NEUROTRANSMISSION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN DETERMINATION; SEROTONINERGIC SYSTEM; WESTERN BLOTTING;

ANIMALS; ESTROGENS; FEMALE; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OVARY; PROGESTERONE; PROTEINS; RALOXIFENE; RAPHE NUCLEI; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 8444243748     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300510     Document Type: Article

References (61)

1. Abell CW, Kwan SW (2001). Molecular characterization of monoamine oxidases A and B. Prog Nucleic Acid Res Mol Biol 65: 129-156.
2. Arai R, Kimura H, Maeda T (1997). Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study. Brain Res 745: 352-356.
3. Banik U, Wang G-A, Wagner PD, Kaufman S (1997). Interaction of phosphorylated tryptophan hydroxylase with 14-3-3 proteins. J Biol Chem 272; 26219-26225.
4. Bethea CL, Lu NZ, Gundlah C, Streicher JM (2002a). Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23: 41-100.
5. Bethea CL, Mirkes SJ, Shively CA, Adams MR (2000). Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 47: 562-576.
6. Bethea CL, Mirkes SJ, Su A, Michelson D (2002b). Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 27: 431-445.
7. Blier P, de Montigny C (1985). Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16: 949-955.
8. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
9. Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M (1999). Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 156: 603-609.
10. Buelke-Sam J, Bryant HU, Francis PC (1998). The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing. Reprod Toxicol 12: 217-221.
11. Celada P, Perez J, Alvarez E, Artigas F (1992). Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. J Clin Psychopharmacol 12: 309-315.
12. Chlebowski RT, Hendrix LL, Langer RD, Stefanick ML, Gass M, Lane D et al (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. J Am Med Assoc 289: 3243-3253.
13. Clement Y, Chapouthier G (1998). Biological bases of anxiety. Neurosci Biobehav Rev 22: 623-633.
14. Dedeoglu A, Fisher A (1994). Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor. Am J Physiol 267: R859-R864.
15. Dumas S, Darmon MC, Delort J, Mallet J (1989). Differential control of tryptophan hydroxylase expression in raphe and in pineal gland: evidence for a role of translation efficiency. J Neurosci 24: 537-547.
16. Florio P, Quirici B, Casarosa E, Lombardi I, Luisi M, Genazzani AD et al (2001). Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women. Gynecol Endocrinol 15: 359-366.
17. Fowler CJ, Tipton KF (1982). Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem 38: 733-736.
18. Fowler CJ, Tipton KF (1984). On the substrate specificities of the two forms of monoamine oxidase. J Pharm Pharmacol 36: 111-115.
19. Furukawa Y, Ikuta N, Omata S, Kamauchi T, Isobe T, Ichimura T (1993). Demonstration of the phosphorylation-dependent interaction of tryptophan hydroxylase with the 14-3-3 protein. Biochem Biophys Res Commun 194: 144-149.
20. Gibbs RB (2000). Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101: 931-938.
21. Gu XF, Azmitia EC (1993). Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons. Eur J Pharmacol 235: 51-57.
22. Gundlah C, Lu NZ, Bethea CL (2001a). Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology 160: 271-282.
23. Gundlah C, Lu NZ, Mirkes SJ, Bethea CL (2001b). Estrogen receptor beta (ERβ) mRNA and protein in serotonin neurons of macaques. Mol Brain Res 91: 14-22.
24. Ichimura T, Uchiyama J, Kunihiro O, Ito M, Horigome T, Omata S et al (1995). Identification of the site of interaction of the 14-3-3 protein with phosphorylated tryptophan hydroxylase. J Biol Chem 270: 28515-28518.
25. Katzenellenbogen BS, Katzenellenbogen JA (2002). Defining the 'S' in SERMs. Science 295: 2380-2381.
26. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE et al (2003). Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 21: 4314-4321.
27. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ et al (2004). Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Cell Biol 15: 1262-1272.
28. Kuhn DM, Arthur Jr R, States JC (1997). Phosphorylation and activation of brain tryptophan hydroxylase: identification of serine-58 as a substrate site for protein kinase A. J Neurochem 68: 2220-2223.
29. 3H] paroxetine, in antidepressant-free depressed suicides. Brain Res 526: 17-22.
30. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
31. Lu NZ, Bethea CL (2002). Ovarian steroid regulation of 5HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27: 12-24.
32. Lu NZ, Eshleman AJ, Janowsky A, Bethea CL (2003). Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution and function in female macaques. Mol Psychiatry 8: 353-360.
33. McLachlan JA, Newbold RR, Nelson KG, Korach KS (1992). Control of uterine epithelial growth and differentiation: implications for estrogen-associated neoplasia. In: Li J, Li S, Nandi R (eds). Hormonal Carcinogenesis. Springer: Verlag, pp 51-57.
34. McQueen JK, Wilson H, Dow RC, Fink G (1996). Oestradiol-17β increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J Physiol 495: 114.
35. Meneses A (1999). 5-HT system and cognition. Neurosci Biobehav Rev 23: 1111-1125
36. Muldoon MF, Mackey RH, Williams KV, Korytkowski MT, Flory JD, Manuck SB (2004). Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. J Clin Endocrinol Metab 89: 266-271.
37. Nagel SC, Hagelbarger JL, McDonnell DP (2001). Development of an ER action indicator mouse for the study of estrogens, selective estrogen receptor modulators (SERMs), and xenobiotics. Endocrinology 142: 4721-4728.
38. Neele SJM, Rombouts SARB, Bierlaagh MA, Barkhof F, Scheltens P, Netelenbos JC (2001). Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 86: 1422-1424.
39. Newhouse PA, Hancur CA, Naylor MR, Kelton M (2002). Estrogen administration blunts anticholinergic-induced psychomotor and attentional impairment in normal postmenopausal women. Biol Psychiatry 51S: 137S.
40. Nilsson S, Gustafsson JA (2000). Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res 2: 360-366.
41. Pecins-Thompson M, Bethea CL (1998). Ovarian steroid regulation of 5HT1A autoreceptor messenger ribonucleic acid expression in the dorsal raphe of rhesus macaques. Neuroscience 89: 267-277.
42. Pecins-Thompson M, Brown NA, Bethea CL (1998). Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol Brain Res 53: 120-129.
43. Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL (1996). Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 16: 7021-7029.
44. Roof RL, Hall ED (2000). Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 17: 367-388.
45. Rothman RB, Baumann MH (2002). Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 71: 825-836.
46. Rudnick G, Wall SC (1993). The molecular mechanism of 'ecstasy' [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci 89: 1817-1821.
47. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH et al (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183: 414-420.
48. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry 5: 97-106.
49. Schwartz S (1991). Women and depression: a Durkheimian perspective. Soc Sci Med 32: 127-140.
50. Shih JC, Chen K, Ridd MJ (1999). Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22: 197-217.
51. Shively CA, Laber-Laird K, Anton RF (1997). The behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry 41: 871-882.
52. Shively CA, Mirkes SJ, Lu NZ, Henderson JA, Bethea CL (2003). Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenom J 3: 114-121.
53. Strickler R, Stovall DW, Merritt D, Shen W, Wong M, Silfen SL (2000). Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 96: 359-365.
54. Von Korff RW (1979). Monoamine Oxidase: Structure, Function and Altered Functions. Academic Press: New York.
55. Walther DJ, Peter J-U, Bashammakh S, Hortnagl H, Voits M, Fink H et al (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299: 76.
56. Weissman MM, Olfson M (1995). Depression in women: implications for health care research. Science 269: 799-808.
57. Westlund KN, Denney RM, Kochersperger LM, Rose M, Abell CW (1985). Distinct monoamine oxidase A and B populations in primate brain. Science 230: 181-182.
58. Westlund KN, Denney RM, Rose RM, Abell CW (1988). Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25: 439-456.
59. Williams JBW, Spitzer RL, Linzer M, Kroenke K, Hahn SR, deGruy FV et al (1995). Gender differences in depression in primary care. Am J Obstet Gynecol 173: 654-659.
60. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M (2001). Neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142: 969-973.
61. Yonders KA, Kando JC, Cole JO, Glumentahl S (1992). Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587-595.